View Older Stories View More Recent Stories
-
Inventiva SA (IVA:FP) (IVA) PT Raised to $42 at H.C. Wainwright
-
H.C. Wainwright Downgrades Dicerna Pharmaceuticals (DRNA) to Neutral Following Takeover
-
Akero Therapeutics (AKRO) PT Lowered to $62 at H.C. Wainwright
-
Arbutus Biopharma (ABUS) PT Lowered to $8 at H.C. Wainwright, Following Earnings, Recent Dilution
-
Albireo Pharma (ALBO) PT Raised to $80 at H.C. Wainwright
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $40 at H.C. Wainwright, Following Earnings
-
UPDATE: H.C. Wainwright Starts Pliant Therapeutics (PLRX) at Buy
-
H.C. Wainwright Downgrades Metacrine Inc. (MTCR) to Neutral
-
Entasis Therapeutics (ETTX) PT Raised to $6 at H.C. Wainwright
-
DURECT Corporation Fireside Chat at the H.C. Wainwright 5th Annual NASH Investor Conference
-
UPDATE: Galectin Therapeutics to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference on October 12, 2021
-
Mirum Pharamceuticals (MIRM) PT Raised to $64 at H.C. Wainwright
-
DURECT Corporation Fireside Chat at the H.C. Wainwright Annual Global Investment Conference
-
5 Penny Stocks To Buy According To Top Wall Street Analysts In 2021
-
CymaBay Therapeutic (CBAY) PT Lowered to $12 at H.C. Wainwright
-
Intercept Pharmaceuticals (ICPT) PT Lowered to $18 at H.C. Wainwright
-
H.C. Wainwright Downgrades Iterum Therapeutics (ITRM) to Neutral
-
H.C. Wainwright Starts Axcella Health Inc. (AXLA) at Buy
-
9 Hot Penny Stocks To Watch Right Now, Analyst Targets Up To 290%
-
UPDATE: H.C. Wainwright Starts Metacrine Inc. (MTCR) at Buy
-
Albireo Pharma (ALBO) PT Raised to $76 at H.C. Wainwright, Following Clinical Business Update
-
5 Penny Stocks Analysts Say To Buy With Targets Up To 219% Right Now
-
H.C. Wainwright Upgrades Iterum Therapeutics (ITRM) to Buy
-
H.C. Wainwright Upgrades Intercept Pharmaceuticals (ICPT) to Neutral
-
UPDATE: H.C. Wainwright Downgrades Intercept Pharmaceuticals (ICPT) to Sell
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $35 as H.C. Wainwright Sees LUPKYNIS Approval As a Watershed Event
-
Arcturus (ARCT) Crashes 37% After 'Underwhelming' COVID-19 Vaccine Data Update, At Least 4 Firms Downgrade
-
4 Penny Stocks On Robinhood Analysts Say Buy & 2 Have 100%+ Targets
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $30 at H.C. Wainwright
-
H.C. Wainwright Starts Arbutus Biopharma (ABUS) at Buy, Sees 100%+ Upside
-
Arcturus Therapeutics (ARCT) PT Raised to $84 at H.C. Wainwright, Following Earnings
-
GrowlerWerks NHL Licensing Deal Gives U.S. and Canadian Hockey Fans a Reason to Celebrate
-
GrowlerWerks NHL Licensing Deal Gives U.S. and Canadian Hockey Fans a Reason to Celebrate
-
DURECT Corporation to Participate in Fireside Chat at H.C. Wainwright 4th Annual NASH Investor Conference
-
DURECT Corporation to Participate in September Virtual Investor Conferences
-
Albireo Pharma (ALBO) PT Raised to $67 at H.C. Wainwright
-
Paratek Pharmaceuticals (PRTK) PT Raised to $19 at H.C. Wainwright
-
Genfit (GNFT) PT Lowered to $8 at H.C. Wainwright
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $33 at H.C. Wainwright
-
Albireo Pharma (ALBO) PT Raised to $64 at H.C. Wainwright
-
Akero Therapeutics (AKRO) PT Raised to $45 at H.C. Wainwright After Ph2a Results
-
Intercept Pharmaceuticals (ICPT) PT Lowered to $48 at H.C. Wainwright, After Receiveing Complete Response Letter From FDA
-
UPDATE: H.C. Wainwright Starts Intercept Pharmaceuticals (ICPT) at Neutral
-
H.C. Wainwright Downgrades Iterum Therapeutics (ITRM) to Neutral
-
Durect Corp (DRRX) PT Raised to $6 at H.C. Wainwright
-
UPDATE: H.C. Wainwright Upgrades CymaBay Therapeutic (CBAY) to Buy
-
H.C. Wainwright Starts Akero Therapeutics (AKRO) at Buy
-
Collegium Pharmaceutical (COLL) PT Raised to $29 at H.C. Wainwright
-
Durect Corp (DRRX) PT Raised to $5.50 at H.C. Wainwright
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $32 at H.C. Wainwright

